CoChat

Synergistic radiosensitization of breast cancer using bismuth oxide nanoparticles coated with chitosan and β-cyclodextrin loaded with curcumin and 5-aminolevulinic acid

Open access
Dastgir, Masoumeh, Ayyami, Yasin, Ghorbani, Marjan, Yektamanesh, Maedeh, Ghasemi Jangjoo, Amir, Zamani, Hamed, Jazzi, Soheila Sharifian, Mehrizi, Omid Abouie, Mortezazadeh, Tohid, Malekzadeh, Reza · 2026 · Cancer Nanotechnology

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Radiotherapy (RT) remains a cornerstone of Breast cancer (BC) treatment, but its effectiveness is hindered by challenges such as tumor hypoxia and lack of selectivity. Nanoparticles (NPs), especially those composed of high-Z materials like bismuth oxide (Bi₂O₃), have emerged as promising radiosensitizers to enhance RT efficacy. This study aims to compare the radiosensitizing effects of two functionalized Bi₂O₃-based NPs, chitosan (CS)-coated Bi₂O₃ NPs conjugated with 5-aminolevulinic acid and curcumin (Bi₂O₃/CS@5-ALA-CUR), and β-cyclodextrin (PCD)-coated Bi₂O₃ NPs conjugated with curcumin and glucose (Bi₂O₃@PCD-CUR-Glu), for targeted BC RT. Two Bi₂O₃-based NP formulations were synthesized and characterized for size, surface charge, and drug loading. Then, NPs were characterized fully. Their radiosensitizing effects were tested in-vitro using SKBr-3 and NIH3T3 cells, assessing cytotoxicity, reactive oxygen species (ROS) generation, and migration inhibition. In-vivo tumor growth inhibition was evaluated in a BALB/c mouse model with 6 MV X-rays (2 Gy) irradiation. Both NP formulations exhibited high biocompatibility and selective cytotoxicity towards SKBr-3 cells, reducing cell viability by 60–69% at 160 µg/mL. Bi₂O₃/CS@5-ALA-CUR NPs showed superior radiosensitization, reducing cell viability by 64% under 2 Gy irradiation. The functionalized NPs enhanced ROS generation, alleviated hypoxia (reducing hypoxic cell viability by 17%), and inhibited migration. In-vivo, Bi₂O₃/CS@5-ALA-CUR NPs combined with 2 Gy irradiation reduced tumor volume by 64%, compared to a 50% reduction with Bi₂O₃@PCD-CUR-Glu NPs. The study demonstrates that Bi₂O₃/CS@5-ALA-CUR NPs are more effective radiosensitizers than Bi₂O₃@PCD-CUR-Glu NPs in BC RT. These findings highlight the potential of modified Bi₂O₃ NPs in overcoming the limitations of traditional RT, providing a promising approach for improving treatment outcomes in BC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12645-025-00359-6

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 57 references

Research works printed but not linked: 4

  1. Abdollahi BB et al (2020) Main approaches to enhance radiosensitization in cancer cells by nanoparticles: a systematic review. Adv Pharm Bull 11(2):212
  2. Khosravi H et al (2024) Bismuth Selenide nanoparticles enhance radiation sensitivity in colon cancer cells in-vitro. Biochem Biophys Rep 38:101732
  3. Yu H et al (2022) Bismuth nanomaterials as contrast agents for radiography and computed tomography imaging and their quality/safety considerations. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol 14(6):e1801
  4. Zare F et al (2026) Targeted radiosensitization in cancer radiotherapy using functionalized nanocarriers: a systematic review.

Cited by

See all 4

Metadata

Authors
Dastgir, M., Ayyami, Y., Ghorbani, M., Yektamanesh, M., Ghasemi Jangjoo, A., Zamani, H., Jazzi, S. S., Mehrizi, O. A., Mortezazadeh, T., & Malekzadeh, R.
Affiliations
Tabriz University of Medical Sciences (IR)
Corresponding author
Malekzadeh, Reza
Venue
Cancer Nanotechnology
Published
2025-12-24
Volume
17
Issue
1
ISSN
  • 1868-6958 (ISSN-L)
  • 1868-6966
OpenAlex
W7117131100
Cited by
4
References
57
Citations by year
2026: 4
FWCI
2.61
Type
journal article
Language
en
Open access
Licence
Locations
Cancer Nanotechnology (publishedVersion, cc-by-nc-nd)
Funders
Tabriz University of Medical Sciences (Grant #75243)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
breast cancer, radiosensitization, bismuth oxide nanoparticles, chitosan coating, β-cyclodextrin, curcumin, 5-aminolevulinic acid, tumor hypoxia, reactive oxygen species, cell migration inhibition, tumor growth inhibition, high-Z nanoparticles, targeted radiotherapy, nanoparticle drug delivery, SK-BR-3 cells, tumor xenografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synergistic radiosensitization of breast cancer using bismuth oxide nanoparticles coated with chitosan and β-cyclodextrin loaded with curcumin and 5-aminolevulinic acid. https://app.cochat.ai/papers/10.1186/s12645-025-00359-6
The paper
Dastgir, M., Ayyami, Y., Ghorbani, M., Yektamanesh, M., Ghasemi Jangjoo, A., Zamani, H., Jazzi, S. S., Mehrizi, O. A., Mortezazadeh, T., & Malekzadeh, R. (2026). Synergistic radiosensitization of breast cancer using bismuth oxide nanoparticles coated with chitosan and β-cyclodextrin loaded with curcumin and 5-aminolevulinic acid. Cancer Nanotechnology. https://doi.org/10.1186/s12645-025-00359-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.